# Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected Children

> **NCT00691288** · PHASE2 · TERMINATED · sponsor: **The Hospital for Sick Children** · enrollment: 13 (actual)

## Conditions studied

- Hypertriglyceridemia

## Interventions

- **DRUG:** Omega Pure followed by placebo
- **DRUG:** Placebo followed by Omega Pure

## Key facts

- **NCT ID:** NCT00691288
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2011-10
- **Final completion:** 2012-12
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Unable to enroll sufficient patients
- **Last updated:** 2014-06-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00691288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00691288, "Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected Children". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00691288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*